Literature DB >> 10431210

NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.

P del Soldato1, R Sorrentino, A Pinto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10431210     DOI： 10.1016/s0165-6147(99)01353-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  29 in total

1.  Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survival.

Authors:  R Ciccone; F Mariani; A Cavone; T Persichini; G Venturini; E Ongini; V Colizzi; M Colasanti
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 2.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

3.  Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

Authors:  Claudio Napoli; Giancarlo Aldini; John L Wallace; Filomena de Nigris; Roberto Maffei; Pasquale Abete; Domenico Bonaduce; Gianluigi Condorelli; Franco Rengo; Vincenzo Sica; Francesco P D'Armiento; Chiara Mignogna; Gaetano de Rosa; Mario Condorelli; Lilach O Lerman; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up.

Authors:  E Alfonso Romero-Sandoval; Javier Mazario; David Howat; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H2O2)-mediated oxidative stress.

Authors:  Somaiah Chinnapaka; Guoxing Zheng; Aoshuang Chen; Gnanasekar Munirathinam
Journal:  Free Radic Biol Med       Date:  2019-08-22       Impact factor: 7.376

6.  Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells.

Authors:  Wilmarie Flores-Santana; Terry Moody; Weibin Chen; Michael J Gorczynski; Mai E Shoman; Carlos Velázquez; Angela Thetford; James B Mitchell; Murali K Cherukuri; S Bruce King; David A Wink
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

7.  NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.

Authors:  P Minuz; M Degan; S Gaino; A Meneguzzi; V Zuliani; C L Santonastaso; P D Soldato; A Lechi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice.

Authors:  Claudio Napoli; Eric Ackah; Filomena De Nigris; Piero Del Soldato; Francesco P D'Armiento; Ettore Crimi; Mario Condorelli; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

9.  Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.

Authors:  Gema Gaitan; F Javier Ahuir; Piero Del Soldato; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

10.  NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.

Authors:  Ravinder Kodela; Mitali Chattopadhyay; Khosrow Kashfi
Journal:  ACS Med Chem Lett       Date:  2012-01-28       Impact factor: 4.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.